131 related articles for article (PubMed ID: 37823695)
1. β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study.
Erb T; Mihai S; Strauß R; Herbst L; Castellanos I; Diesch K; Cipa F; Bihlmaier K; Lang A-K; Ganslmayer M; Willam C; Bremer F; Fürst J; Beyer C; Bogdan C; Rath A; Held J
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072523. PubMed ID: 37823695
[No Abstract] [Full Text] [Related]
2. Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.
Rouzé A; Loridant S; Poissy J; Dervaux B; Sendid B; Cornu M; Nseir S;
Intensive Care Med; 2017 Nov; 43(11):1668-1677. PubMed ID: 28936678
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
4. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
5. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
6. (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Bloos F; Held J; Kluge S; Simon P; Kogelmann K; de Heer G; Kuhn SO; Jarczak D; Motsch J; Hempel G; Weiler N; Weyland A; Drüner M; Gründling M; Meybohm P; Richter D; Jaschinski U; Moerer O; Günther U; Schädler D; Weiss R; Putensen C; Castellanos I; Kurzai O; Schlattmann P; Cornely OA; Bauer M; Thomas-Rüddel D;
Intensive Care Med; 2022 Jul; 48(7):865-875. PubMed ID: 35708758
[TBL] [Abstract][Full Text] [Related]
7. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J
J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667
[TBL] [Abstract][Full Text] [Related]
8. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
[TBL] [Abstract][Full Text] [Related]
9. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
[TBL] [Abstract][Full Text] [Related]
10. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.
Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D
Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
[TBL] [Abstract][Full Text] [Related]
12. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
14. (1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial.
De Pascale G; Posteraro B; D'Arrigo S; Spinazzola G; Gaspari R; Bello G; Montini LM; Cutuli SL; Grieco DL; Di Gravio V; De Angelis G; Torelli R; De Carolis E; Tumbarello M; Sanguinetti M; Antonelli M
Crit Care; 2020 Sep; 24(1):550. PubMed ID: 32891170
[TBL] [Abstract][Full Text] [Related]
15. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
[TBL] [Abstract][Full Text] [Related]
18. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
[TBL] [Abstract][Full Text] [Related]
19. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.
Nucci M; Nouér SA; Esteves P; Guimarães T; Breda G; de Miranda BG; Queiroz-Telles F; Colombo AL
J Antimicrob Chemother; 2016 Sep; 71(9):2628-33. PubMed ID: 27287231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
